SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-15-050219
Filing Date
2015-02-13
Accepted
2015-02-13 16:44:35
Documents
1
Group Members
ANDERS HOVEBONG KOHVHCP CO-INVESTMENT HOLDINGS, LLCVHCP MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d873034dsc13ga.htm SC 13G/A 123109
  Complete submission text file 0001193125-15-050219.txt   124807
Mailing Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301
Business Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301 6504625800
Ocera Therapeutics, Inc. (Subject) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86177 | Film No.: 15615572
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3340 HILLVIEW AVENUE PALO ALTO CA 94306
Business Address 3340 HILLVIEW AVENUE PALO ALTO CA 94306 650-561-9580
VENROCK HEALTHCARE CAPITAL PARTNERS LP (Filed by) CIK: 0001458177 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A